Fundraising FoxBonaventure Equity, LLC
Venture capitalRaleigh · Seed–Series A · 11 people tracked
Find your way into Bonaventure Equity, LLC
Sign up to see every warm intro you have to Bonaventure Equity, LLC
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Bonaventure Equity, LLC team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
BVE is an early-stage healthcare-focused venture firm built by founders for founders, aiming to be a catalyst rather than just a source of capital. Its mission centers on bridging funding gaps in cannabinoid and psychedelic research, backing startups at the frontier of neuroscience and patient care that target conditions such as Alzheimer's, fibromyalgia, PTSD, depression, stroke, and addiction. The firm invests in the advancement of science, works closely with entrepreneurs, and engages with regulatory reform. BVE is currently investing out of its second fund and has 16 portfolio companies.
Source: firm website, verified Aug 7, 2026.
Team · 11 people
from the firm's website & public directories
What they invest in
from 7 of 8 portfolio companiesBiotech ×6AI & Machine Learning ×3Healthtech ×3AgTech ×2Deep Tech ×2Medical Devices ×2Digital Health ×1FoodTech ×1
HQs:United States×5
Investments · 8 tracked
founders shown can be your intro pathBy year:2023 · 12022 · 12021 · 22020 · 15 dated
Engineered Medical develops handheld spectrometers for measuring chemical compounds in agricultural and food products, including cannabinoids, phenolics, and contaminants.
AgTechFoodTech
FloraWorks develops rare and novel cannabinoid-based therapeutic ingredients, focusing on non-intoxicating cannabinoids validated through peer-reviewed research and toxicology testing.
BiotechHealthtechWellness & Fitness
Alleh Lindquist(CEO)in
LeafWorks conducts plant genomics research linking genotypes to agriculturally and commercially relevant traits, and develops DNA-based tests and services for genetic identification of botanical species.
AgTechBiotechDeep TechSebastopol, US
Kerin Law(Executive Officer, Director)inEleanor Kuntz(Executive Officer, Director)inWilliam Kehoe(Executive Officer)Kerin Bentley(Executive Officer, Director)
Nalu Bio develops an AI-powered drug discovery platform targeting the endocannabinoid system to create therapeutics for inflammatory, immune, and metabolic diseases.
AI & Machine LearningBiotechHealthtechMedical DevicesSan Francisco, US
Caitlyn Krebs(Co-founder + CEO)inPhyllis Whiteley(Co-founder + Board Member)inRandall Ussery(Co-founder + Board Member)Howard Goodwin(Director)
Co-investorsFlybridge Capital PartnersPortfoliaGolden Seedsxfactor ventures
Psilera is a biotech company developing neuroscience-focused therapeutics, including its lead asset PSIL-006, described as next-generation mindful medicine.
AI & Machine LearningBiotechDeep TechHealthtechMental HealthTampa, US
Jacqueline Lee Salm(Executive Officer)Jackie von Salm(Co-Founder & Chief Scientific Officer)inChris Witowski(Co-Founder & CEO)inScott Rairigh(EVP, Corporate Development)inMagali Haas(Chief Medical Officer)in
Co-investorsIter InvestmentsMystic Ventures
Sensa Neuroscience is a drug development company creating SEN126, a CBD-derived analog designed to treat refractory epilepsy, including Developmental and Epileptic Encephalopathies (DEEs).
BiotechMedical Devices
Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.
AI & Machine LearningBiotechDigital HealthMedford, US
Jerrold Rosenbaum(Director)inJacob Hooker(Executive Officer, Director)inPranav Tadi(Executive Officer)
BoardRyan Katz(Director)inKevin Lalande(Director)inRichard Simon(Director)
Co-investorsHatteras Venture PartnersIter InvestmentsMission BiocapitalPalo Santo VCRoute 66 VenturesService Provider Capital+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Portfolio news
latest coverage across their companies
Frequently asked questions
- How many investments has Bonaventure Equity, LLC made?
- Bonaventure Equity, LLC has 8 tracked investments.
- What stage does Bonaventure Equity, LLC invest at?
- Bonaventure Equity, LLC invests at the Seed, Series A stages.
- What sectors does Bonaventure Equity, LLC focus on?
- Bonaventure Equity, LLC focuses on Biotech, Digital Health, Healthtech, Medical Devices, Mental Health, Wellness & Fitness.
- Where is Bonaventure Equity, LLC located?
- Bonaventure Equity, LLC is headquartered in Raleigh, US.
- Who does Bonaventure Equity, LLC co-invest with?
- Bonaventure Equity, LLC most often shares deals with Iter Investments, Flybridge Capital Partners, Hatteras Venture Partners, among 9 tracked co-investors.
Similar investors
JAZZ Venture Partners is a venture capital firm investing in early- and growth-stage companies at the intersection of technology, science, and human performance across enterprise, wellness, healthcare, and consumer markets.
LongeVC is a venture capital firm backing early-stage founders in biotech and longevity, aiming to bring breakthrough science and treatments to market.
Foreground Capital is a venture capital firm dedicated to investing in the future of women's health, building on its predecessor track record at RH Capital.
PsyMed Ventures is an early-stage venture firm investing in neuroscience and frontier technologies aimed at improving brain and mental health.
Next Ventures is an investment firm that backs founders building solutions to improve health care access and enhance human capability.